Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37219666)

  • 1. Involvement of CXCL12/CXCR4 axis in colorectal cancer: a mini-review.
    Bocchi M; de Sousa Pereira N; de Oliveira KB; Amarante MK
    Mol Biol Rep; 2023 Jul; 50(7):6233-6239. PubMed ID: 37219666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CXCL12/CXCR4 signaling axis in pancreatic cancer.
    Wu PF; Lu ZP; Cai BB; Tian L; Zou C; Jiang KR; Miao Y
    Chin Med J (Engl); 2013; 126(17):3371-4. PubMed ID: 24033967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTSS1 inhibits colorectal cancer metastasis by regulating the CXCR4/CXCL12 signaling axis.
    Chen L; Chen Q; Wu Y; Zhu M; Hu J; Zhuang Z
    Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33649808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
    Daniel SK; Seo YD; Pillarisetty VG
    Semin Cancer Biol; 2020 Oct; 65():176-188. PubMed ID: 31874281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment.
    Bao S; Darvishi M; H Amin A; Al-Haideri MT; Patra I; Kashikova K; Ahmad I; Alsaikhan F; Al-Qaim ZH; Al-Gazally ME; Kiasari BA; Tavakoli-Far B; Sidikov AA; Mustafa YF; Akhavan-Sigari R
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7945-7968. PubMed ID: 36905421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor CXCR4: role in gastrointestinal cancer.
    Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications.
    Yang Y; Li J; Lei W; Wang H; Ni Y; Liu Y; Yan H; Tian Y; Wang Z; Yang Z; Yang S; Yang Y; Wang Q
    Int J Biol Sci; 2023; 19(11):3341-3359. PubMed ID: 37497001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3.
    Feng W; Huang W; Chen J; Qiao C; Liu D; Ji X; Xie M; Zhang T; Wang Y; Sun M; Tian D; Fan D; Nie Y; Wu K; Xia L
    Theranostics; 2021; 11(6):2612-2633. PubMed ID: 33456563
    [No Abstract]   [Full Text] [Related]  

  • 10. CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver.
    Benedicto A; Romayor I; Arteta B
    Oncol Rep; 2018 Apr; 39(4):2022-2030. PubMed ID: 29436696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.
    Guo F; Wang Y; Liu J; Mok SC; Xue F; Zhang W
    Oncogene; 2016 Feb; 35(7):816-26. PubMed ID: 25961926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy.
    Mousavi A
    Immunol Lett; 2020 Jan; 217():91-115. PubMed ID: 31747563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression Patterns of CXCL12 and its Receptor in Colorectal Carcinoma.
    Mousavi A; Hashemzadeh S; Bahrami T; Estiar MA; Feizi MAH; Pouladi N; Rostamizadeh L; Sakhinia E
    Clin Lab; 2018 May; 64(5):871-876. PubMed ID: 29739049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p.
    Yu X; Wang D; Wang X; Sun S; Zhang Y; Wang S; Miao R; Xu X; Qu X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):32. PubMed ID: 30678736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells.
    Rubie C; Frick VO; Ghadjar P; Wagner M; Justinger C; Faust SK; Vicinus B; Gräber S; Kollmar O; Schilling MK
    J Transl Med; 2011 Feb; 9():22. PubMed ID: 21349176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis.
    Shi J; Wei Y; Xia J; Wang S; Wu J; Chen F; Huang G; Chen J
    Future Oncol; 2014 Apr; 10(5):749-59. PubMed ID: 24799056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages.
    Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X
    Cancer Lett; 2020 Apr; 474():36-52. PubMed ID: 31931030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro.
    Liu Y; Ren CC; Yang L; Xu YM; Chen YN
    J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL12 (SDF-1)/CXCR4 pathway in cancer.
    Teicher BA; Fricker SP
    Clin Cancer Res; 2010 Jun; 16(11):2927-31. PubMed ID: 20484021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.